Replies to post #51830 on NorthWest Biotherapeutics Inc (NWBO)

[TC_Trader]

And what your unique experience is telling me is that this PATENT IS NOW in use for DCVax-L.

I believe they were able to get this PATENT "enhancement" for use in use in this Phase III trial for DCVax-L, and that is a wonderful thing!

You previously said you have a very small stake here, at present. Is this enough info for you to increase at least a little?

[Tony888]

In late 2013 the Company began a pursuit to change the trial, to "enhance it". The process took well into the next year. Shareholders were unaware that the trial was on any clinical halt.

I did not come across any evidence that there was a screening halt during that 9 months. Someone, not naming names, was vigorously promoting this hypothesis here and in IV and now we have a new poster posting some apparent evidence to support his/her hypothesis. I don't know if I can believe all this. Looks very suspicious to me. If there was a halt at that time, why that info did not come to light?

[Reefrad]

It also seems to contradict the notion of a well controlled trial. I dont know how you would be able to account for an essentially different vaccine in the midst of a phase III trial. What you are suggesting is highly unlikely. How do you lump patients with the old vaccine together with the new vaccine??